PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)S. -Y. M. Liu, J. -Y. Deng,H-H. Yan,M. -Y. Yang, C. -R. Xu, M. -Y. Zheng,B. Gan,X. -C. Zhang,H-Y. Tu,J. -J. Yang,H. -J. Chen,B. -C. Wang, Y. Li, Q. Zhou, Y. -L. WuJOURNAL OF THORACIC ONCOLOGY（2023）引用 0|浏览4暂无评分关键词non-small cell lung cancer,pembrolizumab,sintilimabAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
